Society Letters

Endocrine Society Letter to CMS Regarding a 90-Day Supply of Diabetes Test Strips During COVID-19

April 24, 2020

To: CMS Administrator Seema Verma

"Blood glucose self-testing equipment and supplies, like test strips, are covered as durable medical equipment (DME) for all people with Medicare Part B who have diabetes. Medicare will cover up to 100 test strips for 30 days for insulin-dependent beneficiaries. Patients with diabetes check their blood glucose at least once per day and those who are insulin-dependent are recommended to check their levels three times per day. Blood glucose control is even more significant when a patient is ill, as glucose levels are the first impacted by an illness. For these reasons, it is critical that beneficiaries have coverage for a 90-day supply of test strips during the current public health emergency so they can maintain good glucose control and reduce the risk of infection."

arrowRead the Full Letter

Last Updated:
Take Action

Make Your Voice Heard

Take Action
Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!